BERIL-1: Biomarker results from targeted sequencing of circulating tumor DNA (ctDNA) and archival tissue in a randomized phase II study of buparlisib (BKM120) or placebo plus paclitaxel in patients ...
Penn Medicine researchers discover method to identify, prevent recurrence in breast cancer survivors
Researchers at Penn’s Abramson Cancer Center and Perelman School of Medicine recently discovered how to find and treat dormant cancer cells to help identify — and prevent recurrence in breast cancer ...
Researchers have developed and validated a machine learning--based method to predict which patients with early-stage melanoma are most likely to experience a cancer recurrence. Most deaths from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback